1. Home
  2. OPAL vs BRNS Comparison

OPAL vs BRNS Comparison

Compare OPAL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.23

Market Cap

65.8M

Sector

Utilities

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.60

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
BRNS
Founded
1998
2016
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
55.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
OPAL
BRNS
Price
$2.23
$0.60
Analyst Decision
Sell
Strong Buy
Analyst Count
4
1
Target Price
$2.81
$4.00
AVG Volume (30 Days)
180.8K
59.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.85
EPS
0.07
N/A
Revenue
$299,972,000.00
$14,969,000.00
Revenue This Year
$17.25
N/A
Revenue Next Year
$17.23
N/A
P/E Ratio
$28.86
N/A
Revenue Growth
17.13
1766.46
52 Week Low
$1.26
$0.56
52 Week High
$4.08
$2.91

Technical Indicators

Market Signals
Indicator
OPAL
BRNS
Relative Strength Index (RSI) 48.75 39.95
Support Level $2.10 $0.56
Resistance Level $2.49 $0.76
Average True Range (ATR) 0.14 0.07
MACD -0.01 -0.01
Stochastic Oscillator 43.64 21.05

Price Performance

Historical Comparison
OPAL
BRNS

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: